A detailed history of Ayrshire Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ayrshire Capital Management LLC holds 6,694 shares of LLY stock, worth $5.93 Million. This represents 3.22% of its overall portfolio holdings.

Number of Shares
6,694
Previous 6,625 1.04%
Holding current value
$5.93 Million
Previous $5.15 Million 17.6%
% of portfolio
3.22%
Previous 2.93%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$724.87 - $909.04 $50,016 - $62,723
69 Added 1.04%
6,694 $6.06 Million
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $248,724 - $332,757
420 Added 6.77%
6,625 $5.15 Million
Q4 2023

Jan 09, 2024

BUY
$525.19 - $619.13 $141,276 - $166,545
269 Added 4.53%
6,205 $3.62 Million
Q3 2023

Oct 12, 2023

BUY
$434.7 - $599.3 $2.58 Million - $3.56 Million
5,936 New
5,936 $3.19 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $841B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ayrshire Capital Management LLC Portfolio

Follow Ayrshire Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ayrshire Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ayrshire Capital Management LLC with notifications on news.